Five PSA methods compared by assaying samples with defined PSA ratios

Clinical Chemistry

Volumn 43, Issue 5, 1997, Pages 843-845

  Blase, Amy B ^a   Sokoloff, Roger L ^a   Smith, Katie M ^a  

^a Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; AUTOMATION; CHEMOLUMINESCENCE; ENZYME IMMUNOASSAY; HUMAN; PATIENT MONITORING; PROSTATE CANCER; SPECTROPHOTOMETRY;

EID: 0030952402     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.5.843     Document Type: Article

References (21)

1. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific, antigen in patients with prostate cancer. J Urol 1989;142:1011-7.
2. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-90.
3. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-chymotrypsiri is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
4. Christensson A, Bjork T, Nilsson O, Dahlen U, Marikainen MT, Cockett AT, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-5.
5. Catalona WJ, Smith DS, Wolfert L, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;264:1214-20.
6. Elgamel A-AA, Cornillie FJ, Hendrik PV, Van de Voorde WM, McCabe R. Baert LV. Free-to-total for detection of significant stage Tic prostate cancer. J Urol 1996;156:1042-9.
7. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
8. Morale RJ, Ruibal MA, Palou RJ, de Torres MJA, Soler RA. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study. Eur Urol 1988;14:360-6.
9. Glenski WJ, Malek RS, Myrtle JF, Oesterling JE. Sustained, substantially increased concentration of prostate specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario. Mayo Clin Proc 1992;67:249-52.
10. Bankson DD, Lyon ME, Costales LV, Haver VM. The response of assays for total prostate specific antigen to changing proportions of "free" and α1-antichymotrypsin bound PSA [Abstract]. Clin Chem 1994;40:1009.
11. Strobel S, Smith K, Wolfert R, Rittenhouse H. Role of free PSA in discordance across commercial PSA assays [Tech Brief]. Clin Chem 1996;42:645-6.
12. Graves HCB. Standardization of immunoassays for prostate specific antigen. Cancer 1993;72:3141-4.
13. Sokoloff R, Wolfert RL, Rittenhouse HG. Standardization of PSA immunoassays: proposals and practical limitations. J Clin Ligand Assay 1995;18:86-92.
14. Graves HCB, Barren R. Progress towards PSA assay standards. In: Cockett ATK, Aso Y, Chatelain C, Denis L, Griffiths K, Khoury S, Murphy G, eds. Proc., Third International Consultation on Benign Prostate Hyperplasia, Monaco June 26-28, 1995. Paris: SCI Ltd., 1996:404-19.
15. McCormack RT, Wang TJ, Rittenhouse HG, Wolfert RL, Finlay JA, Sokoloff RL, et al. Molecular forms of prostate specific antigen and the human kallikrein gene family: a new era [Review]. Urology 1995;45:729-44.
16. Sensabaugh GF, Blake ET. Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J Urol 1990;144:1523-6.
17. Prestigiacomo AF, Chen Z, Stamey TA. A universal calibrator for prostate specific antigen (PSA). Scand J Clin Lab Invest 1995;55(Suppl 221):57-9.
18. Bankson DD, Petteway JC, Smith AA, Eisenreich CG, Green RE, Haver VM, Brawer MK. A recalibrated CIBA-Corning ACS-180 PSA (PSA2) assay: comparison with the Hybritech Tandem-R and Abbott IMx PSA assays [Abstract]. Clin Chem 1996;42:S266.
19. 2, a new immunoassay for the measurement of prostate specific antigen (PSA) in serum [Abstract]. Clin Chem 1996;42:S265.
20. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39:2483-91.
21. Strobel SA, Sokoloff RL, Wolfert RL, Rittenhouse HG. Multiple forms of prostate-specific antigen in serum measured differently in equimolar and skewed response assays [Letter]. Clin Chem 1995;41:125-7.